Method and System for Evaluating Analyte Sensor Response Characteristics

ABSTRACT

Apparatus, method, system and kit for receiving a plurality of continuous analyte sensor values for corresponding reference analyte values, calculating a rate of change value for the continuous analyte sensor values, defining a plurality of data range windows of the reference analyte values, evaluating the corresponding continuous analyte sensor values, the rate of change values, the reference analyte values, and/or a plurality of corresponding difference values for the plurality of data range windows, and determining a best fit based on the evaluation of the plurality of data range windows are provided.

RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 13/166,797 filed Jun. 22, 2011, now U.S. Pat. No. 8,635,046, which claims the benefit of U.S. Provisional Application No. 61/357,986 filed Jun. 23, 2010 entitled “Method and System for Evaluating Analyte Sensor Response Characteristics”, the disclosures of each of which are incorporated herein by reference for all purposes.

BACKGROUND

Benefits of a closed loop control system for treating diabetic conditions with monitoring glucose levels and adjusting delivery rate of insulin are well known. Such systems, referred to as artificial pancreas, model healthy pancreas which, when functioning normally, produces insulin (by the beta cells (β-cells)) to counteract the rise in glucose levels in the blood stream. As is known, Type-1 diabetes mellitus condition exists when the beta cells in the pancreas either die or are unable to produce sufficient amount of insulin naturally in response to the elevated glucose levels.

Common treatment of Type-1 diabetes is the use of insulin pumps that are programmed to continuously deliver insulin to the body through an infusion set. The use of insulin pumps to treat Type-2 diabetes (where the beta cells in the pancreas do produce insulin, but an inadequate quantity) is also becoming more prevalent. Such insulin delivery devices are preprogrammed with delivery rates such as basal profiles which are tailored to each user, and configured to provide the needed insulin to the user.

In addition, continuous glucose monitoring systems have been developed to provide real time monitoring of fluctuation in glucose levels. One example is the FreeStyle Navigator® Continuous Glucose Monitoring System available from Abbott Diabetes Care Inc., of Alameda, Calif. The use of such glucose monitoring systems provides the user with real time glucose level information. Using the continuous glucose monitoring system, for example, diabetics are able to determine when insulin is needed to lower glucose levels or when additional glucose is needed to raise the level of glucose.

Using a continuous glucose monitoring system in conjunction with an insulin pump can be an effective treatment tool for individuals with Type-1 or severe Type-2 diabetic condition to maintain their blood sugar levels at a physiologically desirable range. However, for the continuous glucose monitoring system to be effective, characteristics of the continuous glucose monitoring system, particularly the continuous glucose sensor of the system, must be evaluated and accurate. Evaluation of characteristics, such as linearity and lag, associated with continuous glucose sensors can impact glucose control errors and previous methods of evaluating such characteristics, such as linearity, can be confounded by lag, noise and apparent nonlinearities due to data distribution.

SUMMARY

Accordingly, a method for evaluating characteristics of a continuous analyte sensor in one aspect of the present disclosure includes receiving a plurality of continuous analyte sensor values for corresponding reference analyte values, calculating a rate of change value for the continuous analyte sensor values, defining a plurality of data range windows of the reference analyte values, evaluating the corresponding continuous analyte sensor values, the rate of change values, the reference analyte values, and/or a plurality of corresponding difference values for the plurality of data range windows, and determining a best fit based on the evaluation of the plurality of data range windows is provided.

In certain aspects, the difference value is the difference between the continuous analyte sensor value and the corresponding reference analyte value and determining the best fit includes determining a least-squares line or relationship based on a graphical representation of the rate of change of glucose values and the difference values for each of the plurality of data range windows.

Certain aspects of the present disclosure include determining a slope and an intercept of the least-squares line for each of the plurality of data range windows and determining a best fit function based on a graphical representation of the intercepts of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows, where the best fit function corresponds to a linearity characteristic of the continuous analyte sensor and determining a best fit function based on a graphical representation of the slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows, where the best fit function corresponds to a lag characteristic of the continuous analyte sensor are provided.

Also provided are systems and kits.

INCORPORATED BY REFERENCE

The following patents, applications and/or publications are incorporated herein by reference for all purposes: U.S. Pat. Nos. 4,545,382; 4,711,245; 5,262,035; 5,262,305; 5,264,104; 5,320,715; 5,356,786; 5,509,410; 5,543,326; 5,593,852; 5,601,435; 5,628,890; 5,820,551; 5,822,715; 5,899,855; 5,918,603; 6,071,391; 6,103,033; 6,120,676; 6,121,009; 6,134,461; 6,143,164; 6,144,837; 6,161,095; 6,175,752; 6,270,455; 6,284,478; 6,299,757; 6,338,790; 6,377,894; 6,461,496; 6,503,381; 6,514,460; 6,514,718; 6,540,891; 6,560,471; 6,579,690; 6,591,125; 6,592,745; 6,600,997; 6,605,200; 6,605,201; 6,616,819; 6,618,934; 6,650,471; 6,654,625; 6,676,816; 6,730,200; 6,736,957; 6,746,582; 6,749,740; 6,764,581; 6,773,671; 6,881,551; 6,893,545; 6,932,892; 6,932,894; 6,942,518; 7,041,468; 7,167,818; and 7,299,082; U.S. Published Application Nos. 2004/0186365; 2005/0182306; 2006/0025662; 2006/0091006; 2007/0056858; 2007/0068807; 2007/0095661; 2007/0108048; 2007/0199818; 2007/0227911; 2007/0233013; 2008/0066305; 2008/0081977; 2008/0102441; 2008/0148873; 2008/0161666; 2008/0267823; and 2009/0054748; U.S. patent application Ser. Nos. 11/461,725, now U.S. Pat. No. 7,866,026; 12/131,012; 12/242,823, now U.S. Pat. No. 8,219,173; 12/363,712, now U.S. Pat. No. 8,346,335; 12/495,709; 12/698,124; 12/714,439; 12/794,721; 12/848,075, now U.S. Pat. No. 8,478,557; and 12/842,013 and U.S. Provisional Application Ser. No. 61/347,754.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a block diagram illustrating a system for evaluating characteristics of a sensor in one or more embodiments of the present disclosure;

FIG. 2 is a flow chart illustrating a method for evaluating characteristics of a sensor response in one or more embodiments of the present disclosure;

FIG. 3 is a plot illustrating a sample data set of continuous glucose values and corresponding reference blood glucose values taken at time instances m;

FIG. 4 is a plot illustrating the sample data set of FIG. 3 with indication of excluded ranges of reference blood glucose values;

FIG. 5 is a plot illustrating a range window of 70 mg/dL to 100 mg/dL of reference glucose values G_(b)(m) for the sample data set of FIG. 3;

FIG. 6 illustrates a best fit line for the range of 70 mg/dL to 100 mg/dL of reference glucose values G_(b)(m) for the sample data set of FIG. 3;

FIG. 7 illustrates a weighted best fit line for the intercepts of the ranges G_(bc)(r) for the sample data set of FIG. 3; and

FIG. 8 illustrates a corrected slope value over the ranges G_(bc)(r) for the sample data set of FIG. 3.

DETAILED DESCRIPTION

Before the present disclosure is described in additional detail, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.

Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges as also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.

It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.

The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.

As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.

The figures shown herein are not necessarily drawn to scale, with some components and features being exaggerated for clarity.

As described in further detail below, in accordance with various embodiments of the present disclosure, there is provided methods and systems for evaluating the response of an analyte sensor. In particular, in certain embodiments, there are provided methods for evaluating the linearity and lag characteristics of an analyte sensor. The analyte sensor, in some embodiments, may be part of an analyte monitoring system, such as a glucose monitoring system, such as a continuous glucose monitoring system. Examples of analyte sensors and analyte monitoring systems to which the disclosed methods may be applied can be found in, for example, among others, U.S. Pat. Nos. 6,103,033, 6,134,461, 6,175,752, 6,284,478 and 6,560,471 and in U.S. patent application Ser. Nos. 12/393,921, 12/698,124 and 12/714,439, the disclosures of each of which are incorporated herein by reference in their entirety for all purposes. The analyte sensors and monitoring systems described herein are described mainly with respect to glucose sensors for use with continuous glucose monitoring systems, however, it is to be appreciated that within the scope of the present disclosure, the described methods may be applied to sensors and monitoring systems configured for detection and measurement of other analytes including, but not limited to, lactate and oxygen, and the sensors may be configured for continuous, substantially continuous, semi-continuous, or periodic measurement.

FIG. 1 is a block diagram illustrating a system for evaluating characteristics of an analyte sensor in one or more embodiments of the present disclosure. Referring to FIG. 1, in some embodiments, a system 100 for evaluating characteristics of an analyte sensor includes an analyte monitoring device 110, the analyte monitoring device 110 including an analyte sensor 111 for which characteristics are to be evaluated, and a transmitter module 112 to enable communication with one or more other devices. The system 100 may also include a receiver unit 120 in data communication with the analyte monitoring device 110 and a data processing unit 130, such as a computer or other microprocessor driven device. Other embodiments of the system 100 include a reference blood glucose meter, such as a conventional in vitro blood glucose meter 140. Example analyte monitoring systems can be found in, among others, U.S. Pat. No. 6,175,752, the disclosure of which is incorporated herein by reference for all purposes.

Referring still to FIG. 1, the analyte sensor 111 of analyte monitoring device 110, in certain embodiments, is a glucose sensor configured for the continuous monitoring of glucose level fluctuation in a patient or fluid sample. In other embodiments, the sensor may be configured to monitor other analytes, drugs, or chemicals, and may be configured for semi-continuous or periodic measurement. The sensor 111 is in communication with a transmitter module 112 of the analyte monitoring device. The transmitter module 112 is configured to transmit wirelessly or via a wired connection, data signals received from the analyte sensor 111 corresponding to the measured analyte level. In certain embodiments, the analyte monitoring device 110 includes other components (not shown) in addition to the analyte sensor 111 and transmitter module 112, including, but not limited to, one or more processing units, one or more memory units, one or more input and/or output units, a temperature detection module, and a power supply. The components of the analyte monitoring device 110 may be integrated into a single housing or, in other embodiments, may be in two or more separate housings in data communication with one another.

The analyte monitoring device 110, in certain embodiments, is in communication with a receiver unit 120 via the transmitter module 112. The receiver unit 120 is configured to process and/or display data received from the analyte monitoring device. The receiver unit 120, in some embodiments, is in communication with a data processing unit 130, which may be, among others, a personal computer or other microprocessor driven device. The data processing unit 130 may be configured to further process data received from the analyte monitoring device 110 via the receiver unit 120, or directly from the analyte monitoring device via a communication link 150. In certain embodiments, the data processing unit 130 is located at a remote location separated from the analyte monitoring device 110 and receiver unit 120 and data is transferred to the data processing unit 130 via a network, such as a local area network or a wide area network via the internet. The data processing unit 130 may further be in communication with a reference blood glucose meter 140 to receive reference values for use in data processing and evaluation. In other embodiments, reference values may be obtained from other reference devices, which may be specifically chosen based upon the desired analyte, drug, or chemical to be analyzed and evaluated.

Each element of the system 100 of FIG. 1 may be individual units, or alternatively, one or more or all of the elements may be integrated into single integrated unit. For example, the reference blood glucose meter 140 may be integrated into the receiver unit 120.

Still referring to FIG. 1, each of the data processing unit 130 and/or the receiver unit 120 or the analyte monitoring device 110 may be configured to process data received from the sensor 111. Processing data from the sensor 111 may include, among others, evaluating characteristics of the sensor 111, such as calculating lag and/or linearity of the sensor response, as will be described in further detail in conjunction with the flow chart of FIG. 2 below.

FIG. 2 is a flow chart illustrating a method for evaluating characteristics of a sensor response in one or more embodiments of the present disclosure. In certain embodiments, a sensor, such as sensor 111 of FIG. 1, is a continuous glucose sensor for which the characteristics, including lag and linearity characteristics are to be evaluated. The evaluation of the sensor characteristics, in some embodiments, is carried out by the data processing unit 130 of the evaluation system 100. In other embodiments, the evaluation is carried out by the receiver unit 120. In still other embodiments, the evaluation is carried out by the analyte monitoring device 110. In accordance with still further embodiments, the evaluation is carried out by a combination of the analyte monitoring device 110, receiver unit 120, and/or the data processing unit 130.

Referring back to FIG. 2, the rate of change of a measured analyte (e.g., glucose) level as measured by the continuous glucose sensor, such as analyte sensor 111 of system 100 of FIG. 1, at a given time k, is determined (210). The rate of change at time k, V_(i)(k), can be calculated, in one embodiment, by choosing or selecting a measurement window with half window N_(hr), such that the analyte level values as measured by the continuous glucose sensor G_(i)(k), in the window are collected {G_(i)(k−N_(hr)), . . . G_(i)(k−1), G_(i)(k), G_(i)(k+1), G_(i)(k+N_(hr))}, and an average rate of change of the analyte level is computed or determined from these points.

In certain embodiments the half window N_(hr) is between 1 and 15 minutes with a measurement window of between 3 and 31 minutes, however, it is to be appreciated that the window could be less than 3 minutes or greater than 31 minutes. In some embodiments, the measurement window duration needed for an accurate rate calculation may be based on the sensor type, such that, for example, a continuous, substantially continuous, or semi-continuous sensor which outputs measured analyte levels at a faster rate than an intermittent or periodic sensor, may require a shorter measurement window duration to obtain enough data points for an accurate rate of change calculation, while a periodic sensor may require a longer measurement window duration in order to obtain enough data points for an accurate rate of change calculation. In another embodiment, the rate of change at time k, V_(i)(k), can be calculated from the slope of a best fit line, such as a least-squares error line, of the points {G_(i)(k−N_(hr)), . . . G_(i)(k−1), G_(i)(k), G_(i)(k+1), . . . G_(i)(k+N_(hr))}. In certain embodiments, the rate of change at time k, V_(i)(k), is calculated by taking two neighboring points G_(i)(k−N_(hr)) and G_(i)(k+N_(hr)), that are half-window N_(hr) samples before and after the glucose level value G_(i)(k), respectively, and then computing the slope between these two neighboring points.

Referring still to FIG. 2, after determination of the rate of change calculation of the continuous glucose sensor (210), the rate of change values V_(i)(m), and the continuous glucose sensor values G_(i)(m) at time m are matched with reference blood glucose values G_(b)(m), at time m (220). Matching the rate of change value and continuous glucose sensor value and the reference blood glucose value at time m generates triplets {G_(b)(m), G_(i)(m), V_(i)(m)}. Reference blood glucose values can be obtained in a variety of ways including measuring a blood glucose value in vitro by applying a blood sample to a test strip and measuring the blood glucose value with a conventional blood glucose monitor, such as the reference blood glucose meter 140 of FIG. 1. FIG. 3 is a plot illustrating a sample data set of continuous glucose values and corresponding reference blood glucose values taken at time instances m. For each of these pairs of matched continuous glucose sensor values G_(i)(m), and reference blood glucose values G_(b)(m), a corresponding continuous glucose rate of change value V_(i)(m), also exists.

Turning back to FIG. 2, in certain embodiments, once the data set of triplets of {G_(b)(m), G_(i)(m), V_(i)(m)} is determined, the triplets are evaluated to determine which triplets are considered reliable data and which triplets are to be excluded due to unreliability (230). In certain embodiments, the evaluation of the triplets may be based on stratified evaluations of the triplet data taken over predetermined ranges of reference blood glucose values G_(b), i.e., wherein each of the predetermined ranges of reference blood glucose values are evaluated individually for the evaluation of the triplets. As such, the evaluations are performed individually on a plurality of groups of reference blood glucose values in order to determine the final result. Furthermore, in certain embodiments, evaluation of each individual range may be utilized for various weighted analysis as described in further detail below. From within each range of reference blood glucose values, the continuous glucose values are evaluated to determine if upper limit or lower limit clipping has occurred. In some embodiments, in evaluated ranges of reference blood glucose values where a significant number of triplets include continuous glucose sensor values G_(i) that are clipped at the upper or lower range, these ranges of reference blood glucose values G_(b) are excluded from the data set. Upper and lower clipping limits may be determined based upon the particular sensor being evaluated. For example, the lower clipping limit, in one sensor embodiment, may be 20 mg/dL and the upper clipping limit may be 500 mg/dL. Further, in certain embodiments, if the number of available continuous glucose value data points within a certain reference blood glucose value G_(b) range is less than a predetermined amount, for example, 100 data points, then these ranges are also excluded from the data set. In another embodiment, the excluded ranges of reference blood glucose values where a significant number of continuous glucose sensor values G_(i) are clipped, can be replaced by the statistical method of left and right censoring.

As illustrated in FIG. 4, the sample data set of FIG. 3 was evaluated for ranges of reference blood glucose values where substantial clipping occurred and ranges of reference blood glucose values where insufficient continuous glucose data points were present. The result of the evaluation of the sample data set was reference blood glucose values G_(b), that fell between 70 mg/dL and 400 mg/dL were evaluated as reliable and the ranges of reference blood glucose values below 70 mg/dL and above 400 mg/dL were excluded from the data set.

Returning to FIG. 2, once the data set of triplets of {G_(b)(m), G_(i)(m), V_(i)(m)} is evaluated and ranges of reference blood glucose values G_(b) are excluded, for example, but not limited to, due to evaluated unreliability as described above, the difference between each continuous glucose sensor value G_(i)(m) and reference blood glucose value G_(b)(m) is calculated for all the non-excluded triplets, whereby the difference value ΔG(m) is determined as follows: ΔG(m)=G_(i)(m)−G_(b)(m). These difference values ΔG(m) are matched with the corresponding triplets, and quadruplets {G_(b)(m), G_(i)(m), V_(i)(m), ΔG(m)} are generated (240).

Still referring to FIG. 2, data range windows of the reference blood glucose values G_(b), are defined (250) based on the reference glucose values G_(b) that were not excluded due to unreliability because of clipping and/or lack of available data points. In certain embodiments, these data range windows of reference blood glucose values G_(b) are used for stratified analysis of the continuous glucose data when compared with the corresponding reference blood glucose data. The stratified analysis allows for individual analysis and evaluation of the continuous glucose data for each of the corresponding data range windows of reference blood glucose values. As such, the evaluations are performed individually on a plurality of groups of reference blood glucose values in order to determine the final result. Furthermore, in certain embodiments, evaluation of each individual data range window may be utilized for various weighted analysis as described in further detail below. The data range windows may be defined based on the overall data range of values, the number of continuous glucose data values available, or other factors. In one embodiment, the data range windows may be defined as 30 mg/dL data range windows beginning at the lowest non-excluded limit of the reference glucose values G_(b).

Referring to FIG. 5, if a data range window of 30 mg/dL is defined, the first data range window of the sample data set of FIGS. 3 and 4 may be from 70 mg/dL to 100 mg/dL. Further, the next data range window may be from 100 mg/dL to 130 mg/dL and so on until the ranges reach the upper non-excluded limit of reference glucose value G_(b). In certain embodiments, the data range windows may overlap, such that a first data range window is from 70 mg/dL to 100 mg/dL and the next data range window is from 80 mg/dL to 110 mg/dL and so on until the upper non-excluded limit of the reference glucose values G_(b) is reached. Within each data range window of the reference glucose values G_(b), there is a center reference blood glucose value, G_(bc)(r). For example, the data range window from 70 mg/dL to 100 mg/dL would have a center reference blood glucose value G_(bc)(r) of 85 mg/dL.

For the data set of FIGS. 3 and 4, in one embodiment, the data range window may be defined as 30 mg/dL, and data range center reference blood glucose value G_(bc)(r) values are at 85, 95, . . . , 375 mg/dL. This also defines the left edges (lower range limit), G_(bl)(r) to 70, 80, . . . , 360 mg/dL and the right edges (upper range limit), G_(br)(r) to 100, 110, . . . , 390 mg/dL. The decision for the distance between the centers of the data range windows, and the amount of overlap (from 0 to almost 100%) may depend on the tradeoff between desired data range resolution (e.g. coarse data range resolution resulting in larger distance between the centers), the allowed maximum correlation between consecutive data ranges (e.g. a smaller allowed maximum correlation results in a smaller allowed percentage of overlap), the available number of data points of the data set used to perform the analysis (e.g. a larger data set allows for shorter distance between the centers of the data range windows and/or smaller amount of overlap), and the type of distribution to be fitted on the data. Appropriate tradeoffs in order to determine the proper distance between the centers of the data range windows and the amount of overlap amongst them would be apparent to those skilled in the art based upon the data set to be evaluated.

Referring back to FIG. 2, once the data range windows for the stratified analysis are defined, for each data range value r, where data range value r is the value of the data range window where data is being evaluated or analyzed, the quadruplets of {G_(b)(m), G_(i)(m), V_(i)(m), ΔG(m)} that fall within each data range window are determined (260). Thus, the quadruplets, with reference blood glucose value at time m G_(b)(m) values that are no smaller than the lower range limit G_(m) and no greater than the upper range limit G_(br), are collected for the particular data range window. Referring again to FIG. 5, as shown, the quadruplets with reference blood glucose value at time m G_(b)(m) values between 70 mg/dL and 100 mg/dL are collected in the data range window with reference blood glucose value for the center of the data range G_(bc)(r)=85 mg/dL.

Once the quadruplets of a particular data range window are determined, a best fit line of the difference value ΔG(m) compared to each rate of change value V_(i)(m) for the data range window is determined (270). In certain embodiments, the best fit line is calculated by setting the rate of change values V_(i)(m) to be on the x-axis and the corresponding difference value, ΔG(m), to be on the y-axis of a scatter plot for a particular data range window and performing a least-squares error fit of a line between the points. The least-squares analysis minimizes the sum of the squared residuals of the points and calculates the best fit line of the points. From the least-squares best fit line, the intercept I(r) and slope S(r) of the particular data range window can be calculated. Further, the number of quadruplets that fall within the data range window N(r), can be determined. It will be appreciated by one skilled in the art that the best fit line may be determined using a variety of functions in addition to or in lieu of a least-squares analysis, and the best fit line may be a linear function, an exponential function, a constant, or any other function type. FIG. 6 illustrates a best fit line for the data range window of 70 mg/dL to 100 mg/dL of reference blood glucose value G_(b)(m) for the sample data set of FIG. 3. As can be seen in the Figure, for the data range center reference blood glucose value G_(bc)(r)=85 mg/dL (i.e. quadruplets where the reference blood glucose G_(b)(m) value is between 70 mg/dL and 100 mg/dL), the intercept I(r) and the slope S(r) are, I(r)=3.4 and S(r)=−10, respectively.

Referring still to FIG. 2, once the best fit lines of each data range window with center reference blood glucose value G_(bc)(r) are calculated and each corresponding intercept I(r) and slope S(r) are determined, the intercept I(r) values are plotted against the corresponding reference blood glucose values for the centers of the data range windows G_(bc)(r) over all the data range windows. A best fit function or line of a scatter plot of all the intercept values plus the data range center reference blood glucose values I(r)+G_(bc)(r) compared to the data range center reference blood glucose values G_(bc)(r) over all the data range windows is determined (280). For the sample data set of FIG. 3, the best fit function may be an affine function or a linear function with an offset, which would suggest a good coherence with a straight line, i.e. a substantially linear response.

As shown in FIG. 7, when data range window center reference blood glucose values G_(bc)(r) are taken on the x-axis and corresponding intercept values plus the data range center reference blood glucose values I(r)+G_(bc)(r) are taken on the y-axis of a graphical representation or plot, if a weighted least-squares best fit straight line is taken between all the points, where the weighting of the least-squares analysis is taken by the number of quadruplets associated with each data range window N(r), the fitness of the line and corresponding affine function of y=0.97x+5.4, validates the linearity of the sensor response of the sensor associated with the data of the sample data set of FIG. 3. For this sample data set, an R² value of 0.9998 is obtained when an affine function is assumed to be the static response of the sensor. In certain embodiments, the determination of the coefficient of determination, R², for a least squares fit of a straight line, is identical to the calculation of the correlation coefficient between the horizontal and vertical axis values of the data points. The calculation of R² is standard practice in statistical methods. In other embodiments, the weights of the weighted least-squares analysis may include scaling by the number of points in each range, scaling by the inverse of the square of the standard error of the intercept in each range, and scaling by the inverse of the square of the standard deviation of the intercept in each range.

In certain embodiments, if the best fit function to data points of intercept values plus the data range center reference blood glucose values I(r)+G_(bc)(r) compared to data range center reference blood glucose values G_(bc)(r) is determined to be not substantially linear, or not an affine function or straight line with an offset, this may be an indication that the response of the sensor being evaluated is not a linear response.

Returning to FIG. 2, a static response corrected slope S_(c)(r) is calculated for each data range window based on the slope S(r) and intercept I(r) for each data range window center reference blood glucose value G_(bc)(r) (290). In some embodiments, the corrected slope S_(c)(r) is calculated as: S_(c)(r)=S(r)*G_(bc)(r)/I(r). As illustrated in FIG. 8, a scatter plot of corrected slope S_(c)(r) values over reference blood glucose at the center of data range window G_(bc)(r) values suggests a constant value across the data range windows of the sample data set of FIG. 3. A weighted average, with the number of quadruplets of each data range N(r) as the weight, may be used to estimate an overall time constant of the lag of the sensor. In some embodiments, the standard error of the weighted average reflects the consistency of the sensor lag over the reference glucose value G_(b) range. In certain embodiments, the weights of the weighted average include scaling by the number of points in each range, scaling by the inverse of the square of the standard error of the intercept in each range, and scaling by the inverse of the square of the standard deviation of the intercept in each range.

In the manner described above, in certain embodiments, analyte sensor characteristics, including sensor lag and sensor linearity, can be determined for a sensor by utilizing sensor data and the methods described above. Determination of these sensor characteristics may be used, in some embodiments, for, for example, artificial pancreas use, such as the user of an insulin pump or insulin dosing for a patient with Type-1 diabetes utilizing an insulin pump in communication with a continuous glucose monitoring system and associated continuous glucose sensor.

In one aspect of the present disclosure, method for evaluating characteristics of a continuous analyte sensor includes receiving a plurality of continuous analyte sensor values for corresponding reference analyte values, calculating a rate of change value for the continuous analyte sensor values, defining a plurality of data range windows of the reference analyte values, evaluating the corresponding continuous analyte sensor values, the rate of change values, the reference analyte values, and/or a plurality of corresponding difference values for the plurality of data range windows, and determining a best fit based on the evaluation of the plurality of data range windows.

In one embodiment, the difference value is the difference between the continuous analyte sensor value and the corresponding reference analyte value.

In another embodiment, determining the best fit includes determining a least-squares line based on a graphical representation of the rate of change values and the difference values for each of the plurality of data range windows.

A further embodiment includes determining a slope and an intercept of the least-squares line for each of the plurality of data range windows.

Another further embodiment includes determining a best fit function based on a graphical representation of the intercepts of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows, wherein the best fit function corresponds to a linearity characteristic of the continuous analyte sensor.

In one embodiment, determining the best fit function includes determining a best fit function based on a weighted graphical representation of the intercepts of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows.

In another embodiment, the weighted graphical representation includes scaling by the number of points in each data range window, scaling by the inverse of the square of the standard error of the slope in each data range window, or scaling by the inverse of the square of the standard deviation of the slope in each data range window.

A further embodiment includes determining a best fit function based on a graphical representation of the slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows, wherein the best fit function corresponds to a lag characteristic of the continuous analyte sensor.

In one embodiment, determining the best fit function includes determining a best fit function based on a weighted graphical representation of the slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows.

In another embodiment, the weighted graphical representation includes scaling by the number of points in each data range window, scaling by the inverse of the square of the standard error of the slope in each data range window, or scaling by the inverse of the square of the standard deviation of the slope in each data range window.

Another further embodiment includes determining a corrected slope for each of the slopes of the least-squares lines of each of the plurality of data range windows and determining a best fit function based on a graphical representation of the corrected slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows, wherein the best fit function corresponds to a lag characteristic of the continuous analyte sensor.

In one embodiment, the corrected slope is determined based on weighted slopes of the least-squares lines of each of the plurality of data range windows.

In another aspect of the present disclosure, an apparatus for evaluating characteristics of a continuous analyte sensor includes one or more processors; and a memory operatively coupled to the one or more processors, the memory storing instructions which, when executed by the one or more processors, causes the one or more processors to receive a plurality of continuous analyte sensor values for corresponding reference analyte values, calculate a rate of change value for the continuous analyte sensor values, define a plurality of data range windows of the reference analyte values, evaluate the corresponding continuous analyte sensor values, the rate of change values, the reference analyte values, and/or a plurality of corresponding difference values for the plurality of data range windows, and determine a best fit based on the evaluation of the plurality of data range windows.

Various other modifications and alterations in the structure and method of operation of this disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the embodiments of the present disclosure. Although the present disclosure has been described in connection with particular embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such particular embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby. 

What is claimed is:
 1. A method, comprising: evaluating, using one or more processors, a plurality of data range windows corresponding to a plurality of reference analyte values by evaluating one or more of a plurality of analyte sensor values from an analyte sensor, a rate of change value for each of the plurality of the analyte sensor values, the plurality of reference analyte values, or a plurality of corresponding difference values; determining, using the one or more processors, a least-squares line based on a graphical representation of the rate of change value for each of the plurality of the analyte sensor values and the corresponding difference values for each of the plurality of data range windows; and determining, using the one or more processors, a linearity characteristic of the analyte sensor based on a graphical representation of one or more of intercepts of the least-squares lines of each of the plurality of data range windows and the reference analyte values at centers of the plurality of data range windows.
 2. The method of claim 1, wherein each of the plurality of corresponding difference values includes a difference between an analyte sensor value and a corresponding reference analyte value.
 3. The method of claim 1, wherein determining the linearity characteristic includes evaluating a weighted graphical representation of the intercepts of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows.
 4. The method of claim 3, wherein the weighted graphical representation includes scaling by a number of points in each of the plurality of data range windows, scaling by an inverse of a square of a standard error of a slope in each of the plurality of data range windows, or scaling by the inverse of the square of a standard deviation of a slope in each of the plurality of data range windows.
 5. The method of claim 1, wherein the analyte sensor values are obtained using the analyte sensor that comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises an analyte-responsive enzyme and a mediator, wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.
 6. A method, comprising: evaluating, using one or more processors, a plurality of data range windows by evaluating one or more of a plurality of analyte sensor values, a rate of change value for each of the plurality of the analyte sensor values, a plurality of reference analyte values, or a plurality of corresponding difference values; determining, using the one or more processors, a least-squares line based on a graphical representation of the rate of change value for each of the plurality of the analyte sensor values and the corresponding difference values for each of the plurality of data range windows; and determining, using the one or more processors, a lag characteristic of an analyte sensor based on a graphical representation of slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at centers of the plurality of data range windows.
 7. The method of claim 6, wherein determining the lag characteristic of the analyte sensor is based on a weighted graphical representation of the slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at the centers of the plurality of data range windows.
 8. The method of claim 7, wherein the weighted graphical representation includes scaling by a number of points in each of the plurality of data range windows, scaling by an inverse of a square of a standard error of a slope in each of the plurality of data range windows, or scaling by the inverse of the square of a standard deviation of a slope in each of the plurality of data range windows.
 9. The method of claim 7, wherein a corrected slope is determined based on weighted slopes of the least-squares lines of each of the plurality of data range windows.
 10. The method of claim 6, wherein the analyte sensor values are obtained using the analyte sensor that comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises an analyte-responsive enzyme and a mediator, wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.
 11. A method, comprising: evaluating, using one or more processors, a plurality of data range windows by evaluating one or more plurality of analyte sensor values, a rate of change value for each of the plurality of the analyte sensor values, a plurality of reference analyte values, or a plurality of corresponding difference values; determining, using the one or more processors, a least-squares line based on a graphical representation of the rate of change value for each of the plurality of the analyte sensor values and the corresponding difference values for each of the plurality of data range windows; determining, using the one or more processors, a slope and an intercept of the least-squares line for each of the plurality of data range windows; and determining, using the one or more processors, a corrected slope for each of the slopes of the least-squares lines of each of the plurality of data range windows and determining a lag characteristic of an analyte sensor based on a graphical representation of the corrected slopes of the least-squares lines of each of the plurality of data range windows and the reference analyte values at centers of the plurality of data range windows.
 12. The method of claim 11, wherein the analyte sensor values are obtained using the analyte sensor that comprises a plurality of electrodes including a working electrode, wherein the working electrode comprises an analyte-responsive enzyme and a mediator, wherein at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer. 